We appreciate your patience. Your content is on the way.
SWOT Analysis
- S
- W
- O
- T
Technical Analysis
Moving Averages
We appreciate your patience. Your content is on the way.
Current Price


- Bullish Moving Averages
- Bearish Moving Averages
Resistance and support
We appreciate your patience. Your content is on the way.
Company Financials
- Profit and loss statement
- Balance sheet
- Quarterly Result
- Ratio
We appreciate your patience. Your content is on the way.
Quick Results Snapshot
We appreciate your patience. Your content is on the way.
Stocks Comparison
Table
Chart
We appreciate your patience. Your content is on the way.
Corporate Action
- Announcement
- Board Meeting
- Dividend
- Split
- Rights
- Events
Insider & Institutional Activity
- Bulk Block Deals
- Insider Trading & SAST
We appreciate your patience. Your content is on the way.
About Marksans Pharma Ltd
Stock PE (TTM)
Promoter Holding
Book Value
ROCE
ROE
Marksans Pharma Limited is a pharmaceutical company and has a market capitalization of Rs. 2,916 crores as of 18th August 2021. The company started on 16th April 1992. The company has reported a total quarterly income of Rs.354.84 crores at the end of June 2021. The Bombay Stock Exchange (BSE) and National Stock Exchange have assigned the number 524404 and scrip code MARKSANS. As of 18th August 2021, Marksans Pharma’s shares were trading at Rs. 71.25.
The corporate is engaged in the research, manufacturing, and marketing of generic pharmaceutical formulations. The company’s research and development centres are in Verna Goa and Navi Mumbai, respectively. With three manufacturing facilities in India, UK, and therefore the US, Marksans has established an authoritative position in regulated markets in India and abroad. The company currently has approximately 1200 employees globally with more than 500 registered products. It also has 50+ experienced scientists in the R& D facility. The promoter holding stood at 48.25% in June 2021 and has remained constant over the last 15 months. Promoters have zero pledged holdings.
In June 2021, the company reported total revenue of Rs. 354.84 crores as compared to Rs. 336.21 crores during the quarter ended March 2021. It had posted net profit / (loss) of Rs. 62.60 crores for the period ended June 2021 as compared to net profit / (loss) of Rs.79.49 crores for the period ended 31st March 2021. The company’s EPS was at Rs.1.51 for the period ended 30th June '2021, as against Rs.1.93 for the period ended 31st March '2021. On a year-on-year basis, the total income of the company has increased 7.10% from Rs. 331.33 crores to Rs. 354.84 crores with the net profit increasing 26.82% from Rs. 49.36 crores to Rs. 62.60 crores and with EPS increasing 25.83% to Rs. 1.51 as against Rs. 1.2 in June 2020. Over the last 5 years, the company’s market share has increased from 0.49% to 0.54%. Marksans Pharma’s shares closed at Rs. 71.25 (NSE) as of 18th August 2021 and has given a return of 30.38% over the last 12 months.
Marksans Pharma share price as on 16 May 2025 is Rs. 239.61. Over the past 6 months, the Marksans Pharma share price has decreased by 22.28% and in the last one year, it has increased by 51.03%. The 52-week low for Marksans Pharma share price was Rs. 130 and 52-week high was Rs. 358.7.
524404
MARKSANS
INE750C01026
Sep
Marksans Pharma Ltd FAQs
You can buy Marksans Pharma Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Marksans Pharma Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of May 15, 2025 04:06 PM the closing price of Marksans Pharma Ltd was Rs.239.61.
The latest PE ratio of Marksans Pharma Ltd as of May 15, 2025 04:06 PM is 29.44
The latest PB ratio of Marksans Pharma Ltd as of May 15, 2025 04:06 PM is 0.21
The 52-week high of Marksans Pharma Ltd share price is Rs. 358.70 while the 52-week low is Rs. 130.00
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of May 15, 2025 04:06 PM, the market cap of Marksans Pharma Ltd stood at Rs. 10,858.26 Cr.
Market Outlook
View allWe appreciate your patience. Your content is on the way.